Skip to main
  1. Stocks
  2. Alignment Healthcare
  3. Forecast
ALHC

Alignment Healthcare (ALHC) Stock Forecast & Price Target

Alignment Healthcare (ALHC) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 57%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Alignment Healthcare is viewed positively because its consumer-centric Medicare Advantage model is gaining share in a supportive industry backdrop, aided by differentiated AVA technology, local provider partnerships, and management’s experience as traditional carriers narrow their footprints. Membership reached approximately 294k in 2Q26, up 31% year over year, while revenue rose 32% to $1.3B and adjusted EBITDA increased 48% to $68mm, showing that scale is translating into operating leverage. The core long-term driver is the estimated ~$880mm of embedded gross profit potential in the existing membership base, with improving MBR to 86.3%, 4-star-or-better quality on six of seven eligible contracts, and $702mm of cash and investments supporting execution.

Bears say

Alignment Healthcare is viewed cautiously because its 3Q26 EBITDA of $21.8 million only narrowly missed expectations while full-year 2026 EBITDA guidance was cut sharply to “no less than” $100 million from a $154 million midpoint, signaling weaker earnings power and a higher MLR. The outlook is further pressured by the loss of its largest H3815 contract’s 4.0-star rating for bonus year 2028, which puts about 75% of membership below the 4-star threshold and creates material uncertainty around plan economics, benefit flexibility, and 2028 profitability. Added to this are persistent institutional acute care cost pressures, approximately $10 million to $11 million of second-half investment spending, and the fact that 100% of the business is exposed to Medicare Advantage reimbursement and utilization risk with limited diversification.

Alignment Healthcare (ALHC) has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 57% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Alignment Healthcare (ALHC) Analyst Forecast & Price Prediction

Get the latest Alignment Healthcare (ALHC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Alignment Healthcare (ALHC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alignment Healthcare (ALHC) Forecast

Analysts have given Alignment Healthcare (ALHC) a Buy based on their latest research and market trends.

According to 7 analysts, Alignment Healthcare (ALHC) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $13.71, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $13.71, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alignment Healthcare (ALHC)


Alignment Healthcare (ALHC) Analyst Forecast & Price Prediction

Get the latest Alignment Healthcare (ALHC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Alignment Healthcare (ALHC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover ALHC stock data and trends